Serial Number
97198814
Owner
Revir Therapeutics, Inc.Attorney
Enshan HongFirst Use Date
Jun 14, 2023
Filing Date
Dec 31, 2021
Serial #97198814 Trademark
Serial Number: 97198814 • Registration: 7356212
Trademark Classes
Owner Contact Info
969 G Edgewater Blvd, Suite #185
Foster City, CA 94404
Entity Type: 03
Legal Representation
Trademark Details
Filing Date
December 31, 2021
Registration Date
April 9, 2024
First Use Anywhere
June 14, 2023
First Use in Commerce
June 14, 2023
Published for Opposition
November 8, 2022
Goods & Services
Scientific research in the field of genetics and genetic engineering; Scientific research consulting in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Medical and scientific research in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Scientific research and development; Scientific research and development of diagnostic methods and test processes; Scientific research and development related to technical planning and conducting of projects in the field of the supplying of medicines; Scientific consultancy services in the field of research and development of therapies and medical preparations; Provision of scientific expertise in the nature of scientific study and research in the field of medicine; Scientific research and development for medical and veterinary purposes; Medical and scientific research in the field of treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, and neurodegenerative disease, metabolic diseases; Providing medical and scientific research information, consultancy, and advisory services in the fields of treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, and neurodegenerative disease; Compiling data for medical and scientific research, clinical trials, and drug admission
